Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick N Harter

Showing results (21-30 of 205) with videos related to

Pageof 21
Sort By:
Oncology Letters|November 4, 2017
ASA404, a vascular disrupting agent, as an experimental treatment approach for brain tumorsOliver Bähr, Stefanie Gross, Patrick N Harter, et al.
Journal of Pediatric Gastroenterology and Nutrition|August 9, 2024
Diagnosis of Hirschsprung disease by analyzing acetylcholinesterase staining using artificial intelligenceYannick Braun, Florian Friedmacher, Till-Martin Theilen, et al.
Anesthesiology|April 26, 2012
Adora2b signaling on bone marrow derived cells dampens myocardial ischemia-reperfusion injuryMichael Koeppen, Patrick N Harter, Stephanie Bonney, et al.
Journal of Clinical Medicine|August 17, 2018
Ventriculoperitoneal Shunts Equipped with On-Off Valves for Intraventricular Therapies in Patients with Communicating Hydrocephalus due to Leptomeningeal MetastasesMichael C Burger, Marlies Wagner, Kea Franz, et al.
International Journal of Molecular Sciences|November 22, 2017
Bevacizumab for Patients with Recurrent Multifocal GlioblastomasMichael C Burger, Stella Breuer, Hans C Cieplik, et al.
Neurological Research and Practice|December 14, 2023
The impact of referring patients with drug-resistant focal epilepsy to an epilepsy center for presurgical diagnosisLeonhard Mann, Felix Rosenow, Adam Strzelczyk, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 20, 2011
Survivin inhibition and DNA double-strand break repair: a molecular mechanism to overcome radioresistance in glioblastomaSebastian Reichert, Claus Rödel, Johanna Mirsch, et al.
Acta Neuropathologica|July 21, 2011
Macrophage migration inhibitory factor (MIF) expression in human malignant gliomas contributes to immune escape and tumour progressionMichel Mittelbronn, Michael Platten, Pia Zeiner, et al.
Journal of Neurology|February 1, 2018
New MR perfusion features in primary central nervous system lymphomas: pattern and prognostic impactStella Blasel, Rieke Vorwerk, Makoto Kiyose, et al.
Cancers|March 13, 2019
Therapeutic Targeting of Stat3 Using Lipopolyplex Nanoparticle-Formulated siRNA in a Syngeneic Orthotopic Mouse Glioma ModelBenedikt Linder, Ulrike Weirauch, Alexander Ewe, et al.
Pageof 21

Showing results (21-30 of 205) with videos related to

Sort By:
Pageof 21
Oncology Letters|November 4, 2017
ASA404, a vascular disrupting agent, as an experimental treatment approach for brain tumorsOliver Bähr, Stefanie Gross, Patrick N Harter, et al.
Journal of Pediatric Gastroenterology and Nutrition|August 9, 2024
Diagnosis of Hirschsprung disease by analyzing acetylcholinesterase staining using artificial intelligenceYannick Braun, Florian Friedmacher, Till-Martin Theilen, et al.
Anesthesiology|April 26, 2012
Adora2b signaling on bone marrow derived cells dampens myocardial ischemia-reperfusion injuryMichael Koeppen, Patrick N Harter, Stephanie Bonney, et al.
Journal of Clinical Medicine|August 17, 2018
Ventriculoperitoneal Shunts Equipped with On-Off Valves for Intraventricular Therapies in Patients with Communicating Hydrocephalus due to Leptomeningeal MetastasesMichael C Burger, Marlies Wagner, Kea Franz, et al.
International Journal of Molecular Sciences|November 22, 2017
Bevacizumab for Patients with Recurrent Multifocal GlioblastomasMichael C Burger, Stella Breuer, Hans C Cieplik, et al.
Neurological Research and Practice|December 14, 2023
The impact of referring patients with drug-resistant focal epilepsy to an epilepsy center for presurgical diagnosisLeonhard Mann, Felix Rosenow, Adam Strzelczyk, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 20, 2011
Survivin inhibition and DNA double-strand break repair: a molecular mechanism to overcome radioresistance in glioblastomaSebastian Reichert, Claus Rödel, Johanna Mirsch, et al.
Acta Neuropathologica|July 21, 2011
Macrophage migration inhibitory factor (MIF) expression in human malignant gliomas contributes to immune escape and tumour progressionMichel Mittelbronn, Michael Platten, Pia Zeiner, et al.
Journal of Neurology|February 1, 2018
New MR perfusion features in primary central nervous system lymphomas: pattern and prognostic impactStella Blasel, Rieke Vorwerk, Makoto Kiyose, et al.
Cancers|March 13, 2019
Therapeutic Targeting of Stat3 Using Lipopolyplex Nanoparticle-Formulated siRNA in a Syngeneic Orthotopic Mouse Glioma ModelBenedikt Linder, Ulrike Weirauch, Alexander Ewe, et al.
Pageof 21